Motor neuron diseases (MNDs) are a group of progressive neurological disorders that affect the motor neurons in the brain and spinal cord. The motor neurons are responsible for controlling voluntary muscle movement such as speaking, walking, and breathing. Over time, MNDs can result in muscle weakness and paralysis. The causes of MNDs are not completely understood. Some forms of MNDs run in families, while others are caused by exposure to toxic substances or infections. Exposure to environmental factors like toxins or excess stress may increase with susceptibility to MNDs. Mylestated diseases, amyotrophic lateral sclerosis (ALS), progressive muscular atrophy (PMA), primary lateral sclerosis (PLS), progressive bulbar palsy (PBP), primary muscular atrophy (PMA) and inherited motor neuron syndromes such as hereditary motor neuron pathology (HMN) are some common types of MNDs. Symptoms of MNDs may vary from one individual to another depending on the specific disorder. In general, the most common symptom is muscle weakness and/or paralysis, which can begin in the limited area such as a single hand or foot and progress to other parts of the body. Additional symptoms can include muscle wasting, twitching, stiffness, difficulty in speaking and swallowing, and difficulty in breathing. Diagnosis of MNDs is done through a physical examination, imaging tests, blood and urine tests, and a number of nerve tests. Treatment options for MNDs vary depending on the disorder and severity of the symptoms. Medications may be used to slow down the progression of the disease, while physical therapy, occupational therapy, and supportive devices such as braces and wheelchairs can help maintain muscle function. In some cases, surgery and stem cell therapy may also be recommended. The prognosis for MNDs is typically worse than other types of neurological disorders because of the progressive nature of the disorder. However, with the use of early diagnosis and the right treatment, the progression of MNDs can be slowed down and the affected individuals can live longer and more comfortable lives.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Examining the effects of prenatal neurotoxin exposure on the development of the prefrontal cortex and its impact on executive functioning and attentional capacities in children
David Joseph Sperbeck, Private practice, United States
Title : Neurojourney: A free, digital, and multilingual anticipatory guidance tool for parents and clinicians caring for children with severe neurological impairment
Blyth Lord, Courageous Parents Network, United States
Title : Beyond individual choice: How social influence shapes the neural foundations of economic decision-making
Alvina Ashraf, Eastern Regional High School, United States
Title : Mapping the cytokine landscape in Alzheimer’s disease: A bibliometric analysis of global trends and emerging themes
Anagha Kumble, ThinkNeuro, United States